Facial Rejuvenation Market By Product Type (Topical Rejuvenation Products (Keratolytics, Moisturizers, Retinoids, Sunscreens, Hair Removals), Botulinum Products, (Dermal Fillers (Absorbable, Nonabsorbable), Chemical peels, Micro abrasion equipment, Equipment (Laser based equipment, Ultrasound-based equipment), By End-user (Hospitals, Dermatology clinics, Others) and Geography.    

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Facial Rejuvenation Market size was valued at USD 24,413.7 million in 2022, growing at a CAGR of 7.6% from 2023-29. Facial rejuvenation is a combination of medical and cosmetic procedures that are carried out a youthful appearance to the human face. Facial rejuvenation is carried out by either minimally invasive or non-invasive treatment which aims to restore skin elasticity and enables maintaining a youthful appearance in the neck and face region. Facial rejuvenation plays a vital role in skin protection from sun damage. At young ages, human naturally defend their bodies from sun damage by neutralization free radicals which are reactive oxygen atoms that damage the skin's collagen. However, human bodies lose their resistance to ultraviolet radiation in older age. The signs of sun damage include wrinkles, enlarged pores, sagging skin, freckling or spotting, and spider veins. Many treatments such as microabrasion, dermabrasion, topical creams, chemical peels, dermal fillers, and cosmetic surgery are available for the protection of skin from sun damage. Market players are adopting various key strategies that include acquisitions and mergers, collaborations, agreements, product approvals, and the launching of new products to increase share in the facial rejuvenation market.

Facial Rejuvenation Market Key Developments:

  • In April 2016, Galderma Announced U.S. Collaboration in Aesthetics with Mentor Worldwide, LLC In March 2016, Merz received the European approval for Bocouture used to treat upper facial lines
  • In June 2009, Anika Therapeutics, signed an exclusive U.S. distribution agreement with Palo Alto, Coapt Systems, Inc. for its aesthetic dermatology franchise. Coapt Systems suite of bioabsorbable implants for use in facial aesthetic and rejuvenation procedures is highly complementary to Anikas injectable filler that corrects lines and wrinkles on the face. In addition,
  • In July 2008, Johnson & Johnson received U.S. Food and Drug Administration clearance to market Evolence, an injectable collagen for treating facial wrinkles. Moreover,
  • In April 2016, Merz Pharma made a strategic venture investment in Cytrellis Biosystems, for developing a new class of non-surgical products to combat sagging skin associated with aging.  

 

Global Facial Rejuvenation Market Summary

Study Period

2023-29

Base Year

2022

CAGR

7.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Facial Rejuvenation Market Dynamics

The global Facial Rejuvenation market is expected to grow at a significant CAGR due to increase in the global population. Rise in the disposable income levels, lifestyle changes, early onset of aging, and increasing adoption of minimally invasive or non-invasive surgical rejuvenation procedures expected fuel the facial rejuvenation market. Furthermore, simple procedures for the treatments, rise in the affordability, availability of beauty products in the market, and shorter treatment duration by patients also boost the facial rejuvenation market over the forecast period. However, lack of properly trained professionals, limited documented evidence of clinical effectiveness, and the implementation of international regulatory mandates for the standardization of cosmetic procedures are the major bottle necks for the growth of facial rejuvenation market over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Facial Rejuvenation Market Segmentation

By Product Type
  • Topical Rejuvenation Products
    • Keratolytics
    • Moisturizers
    • Retinoids
    • Sunscreens
    • Hair Removals
  • Botulinum Products
  • Dermal Fillers
    • Absorbable
    • Non absorbable
  • Chemical peels
  • Micro abrasion equipment
  • Equipment
By End User
  • Hospitals
  • Dermatology clinics
  • Others

Frequently Asked Questions

The facial rejuvenation market size was valued at USD 24,413.7 million in 2022

The facial rejuvenation market key players are: Biopolymer GmbH & Co KG (Germany) Merz GmbH & Co. KGaA (Germany) Lumenis (U.S.) Revance Therapeutics, Inc. (U.S) Speciality European Pharma (U.K.) Mentor Worldwide LLC (U.K.) Anika Therapeutics, Inc. (U.S.) Contura International A/S (Denmark) Cynosure, Inc. (U.S.) Fibrocell Science Inc. (U.S) Galderma S/A (Switzerland)

The facial rejuvenation market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary

2. Global Facial Rejuvenation Market Introduction

2.1. Global Facial Rejuvenation Market  Taxonomy

2.2. Global Facial Rejuvenation Market Definitions

2.2.1. Product

2.2.2. End-Use

3. Global Facial Rejuvenation Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Facial Rejuvenation Market Dynamics Factors Impact Analysis

3.6. Global Facial Rejuvenation Market Regulations

3.6.1. U.S.

3.6.2. Europe

3.6.3. Japan

3.7. Global Facial Rejuvenation Market Product Pipeline Analysis

4. Global Facial Rejuvenation Market Analysis, 2018 - 2022 and Forecast, 2022 - 2029

4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Oppurtunity Analysis

5. Global Facial Rejuvenation Market, By Product, 2018 - 2022 and Forecast, 2023 - 2029

5.1. Topical Rejuvenation Products

5.1.1. Keratolytics

5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.1.3. Market Opportunity Analysis

5.1.2. Moisturizers

5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.3. Market Opportunity Analysis

5.1.3. Retinoids

5.1.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3.3. Market Opportunity Analysis

5.1.4. Sunscreens

5.1.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.4.3. Market Opportunity Analysis

5.1.5. Hair Removals

5.1.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.5.3. Market Opportunity Analysis

5.2. Botulinum Products

5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.1.3. Market Opportunity Analysis

5.3. Dermal Fillers

5.3.1. Absorbable

5.3.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.1.3. Market Opportunity Analysis

5.3.2. Non absorbable

5.3.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.2.3. Market Opportunity Analysis

5.4. Chemical peels

5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Micro abrasion equipment

5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

5.6. Equipment

5.6.1. Laser based equipment

5.6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.6.1.3. Market Opportunity Analysis

5.7. Ultrasound-based equipment

5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.7.3. Market Opportunity Analysis

6. Global Facial Rejuvenation Market Forecast, By End-Use, 2018 - 2022 and Forecast, 2023 - 2029

6.1. Hospital Pharmacies

6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Dermatology Clinics

6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Others

6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

7. Global Facial Rejuvenation Market Forecast, By Region, 2018 - 2022 and Forecast, 2023- 2029

7.1. North America

7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Europe

7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Asia-Pacific

7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Latin America

7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Middle East and Africa

7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Global Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use, and Region, 2023 - 2029

8. North America Facial Rejuvenation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

8.1. Product Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

8.1.1. Topical Rejuvenation Products

8.1.1.1. Keratolytics

8.1.1.2. Moisturizers

8.1.1.3. Retinoids

8.1.1.4. Sunscreens

8.1.1.5. Hair Removals

8.1.2. Botulinum Products

8.1.3. Dermal Fillers

8.1.3.1. Absorbable

8.1.3.2. Non absorbable

8.1.4. Chemical peels

8.1.5. Micro abrasion equipment

8.1.6. Equipment

8.1.6.1. Laser based equipment

8.1.7. Ultrasound-based equipment

8.1.8. Others

8.2. End-Use Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

8.2.1. Hospital Pharmacies

8.2.2. Dermatology Clinics

8.2.3. Others

8.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

8.3.1. U.S.

8.3.2. Canada

8.4. North America Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2023 - 2029

8.5. North America Facial Rejuvenation Market Dynamics Trends

9. Europe Facial Rejuvenation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

9.1. Product Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Topical Rejuvenation Products

9.1.1.1. Keratolytics

9.1.1.2. Moisturizers

9.1.1.3. Retinoids

9.1.1.4. Sunscreens

9.1.1.5. Hair Removals

9.1.2. Botulinum Products

9.1.3. Dermal Fillers

9.1.3.1. Absorbable

9.1.3.2. Non absorbable

9.1.4. Chemical peels

9.1.5. Micro abrasion equipment

9.1.6. Equipment

9.1.6.1. Laser based equipment

9.1.7. Ultrasound-based equipment

9.1.8. Others

9.2. End-Use Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1. Hospital Pharmacies

9.2.2. Dermatology Clinics

9.2.3. Others

9.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.3.1. Germany

9.3.2. UK

9.3.3. France

9.3.4. Spain

9.3.5. Italy

9.3.6. Russia

9.3.7. Poland

9.3.8. Rest of Europe

9.4. Europe Facial Rejuvenation Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product, By End-Use and Country, 2023 - 2029

9.5. Europe Facial Rejuvenation Market Dynamics Trends

10. Asia-Pacific Facial Rejuvenation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

10.1. Product Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Topical Rejuvenation Products

10.1.1.1. Keratolytics

10.1.1.2. Moisturizers

10.1.1.3. Retinoids

10.1.1.4. Sunscreens

10.1.1.5. Hair Removals

10.1.2. Botulinum Products

10.1.3. Dermal Fillers

10.1.3.1. Absorbable

10.1.3.2. Non absorbable

10.1.4. Chemical peels

10.1.5. Micro abrasion equipment

10.1.6. Equipment

10.1.6.1. Laser based equipment

10.1.7. Ultrasound-based equipment

10.1.8. Others

10.2. End-Use Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Hospital Pharmacies

10.2.2. Dermatology Clinics

10.2.3. Others

10.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.3.1. Japan

10.3.2. China

10.3.3. India

10.3.4. ASEAN

10.3.5. Australia & New Zealand

10.3.6. Rest of Asia-Pacific

10.4. Asia-Pacific Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2023 - 2029

10.5. Asia-Pacific Facial Rejuvenation Market Dynamics Trends

11. Latin America Facial Rejuvenation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

11.1. Product Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Topical Rejuvenation Products

11.1.1.1. Keratolytics

11.1.1.2. Moisturizers

11.1.1.3. Retinoids

11.1.1.4. Sunscreens

11.1.1.5. Hair Removals

11.1.2. Botulinum Products

11.1.3. Dermal Fillers

11.1.3.1. Absorbable

11.1.3.2. Non absorbable

11.1.4. Chemical peels

11.1.5. Micro abrasion equipment

11.1.6. Equipment

11.1.6.1. Laser based equipment

11.1.7. Ultrasound-based equipment

11.1.8. Others

11.2. End-Use Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Hospital Pharmacies

11.2.2. Dermatology Clinics

11.2.3. Others

11.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Brazil

11.3.2. Mexico

11.3.3. Argentina

11.3.4. Venezuela

11.3.5. Rest of Latin America

11.4. Latin America Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2023 - 2029

11.5. Latin America Facial Rejuvenation Market Dynamics Trends

12. Middle East and Africa Facial Rejuvenation Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

12.1. Product Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Topical Rejuvenation Products

12.1.1.1. Keratolytics

12.1.1.2. Moisturizers

12.1.1.3. Retinoids

12.1.1.4. Sunscreens

12.1.1.5. Hair Removals

12.1.2. Botulinum Products

12.1.3. Dermal Fillers

12.1.3.1. Absorbable

12.1.3.2. Non absorbable

12.1.4. Chemical peels

12.1.5. Micro abrasion equipment

12.1.6. Equipment

12.1.6.1. Laser based equipment

12.1.7. Ultrasound-based equipment

12.1.8. Others

12.2. End-Use Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Hospital Pharmacies

12.2.2. Dermatology Clinics

12.2.3. Others

12.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Gulf Cooperation Council (GCC) Countries

12.3.2. Israe

l12.3.3. South Africa

12.3.4. Rest of MEA

12.4. MEA Facial Rejuvenation Market - Opportunity Analysis Index, By Product, By End-Use and Country, 2023 - 2029

12.5. MEA Facial Rejuvenation Market Dynamics – Trends

13. Competition Landscape

13.1. Strategic Dashboard of Top Market Players

13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

13.2.1. Biopolymer GmbH & Co KG (Germany)

13.2.2. Merz GmbH & Co. KGaA (Germany)

13.2.3. Lumenis (U.S.)

13.2.4. Revance Therapeutics, Inc. (U.S)

13.2.5. Speciality European Pharma (UK)

13.2.6. Mentor Worldwide LLC (UK)

13.2.7. Anika Therapeutics, Inc. (U.S.)

13.2.8. Contura International A/S (Denmark)

13.2.9. Cynosure, Inc. (U.S.)

13.2.10. Fibrocell Science Inc. (U.S)

13.2.11. Galderma S/A (Switzerland)

14. Research Methodology

15. Key Assumptions and Acronyms

  • Biopolymer GmbH & Co KG (Germany)
  • Merz GmbH & Co. KGaA (Germany)
  • Lumenis (U.S.)
  • Revance Therapeutics, Inc. (U.S)
  • Speciality European Pharma (U.K.)
  • Mentor Worldwide LLC (U.K.)
  • Anika Therapeutics, Inc. (U.S.)
  • Contura International A/S (Denmark)
  • Cynosure, Inc. (U.S.)
  • Fibrocell Science Inc. (U.S)
  • Galderma S/A (Switzerland)